Government funding of cancer research in Brazil

被引:1
|
作者
da Silva, Cecilia Ferreira [1 ]
de de Lima, Luciana Dias [2 ]
Serpa Osorio-de-Castro, Claudia Garcia [3 ]
机构
[1] Brazilian Natl Canc Inst INCA, Clin Res Div, 37 Andre Cavalcanti St, BR-20231050 Rio De Janeiro, RJ, Brazil
[2] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Dept Hlth Adm & Planning, 1480 Leopoldo Bulhoes St, BR-21041210 Rio De Janeiro, RJ, Brazil
[3] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Dept Med Policy & Pharmaceut Serv, 1480 Leopoldo Bulhoes St, BR-21041210 Rio De Janeiro, RJ, Brazil
来源
JOURNAL OF CANCER POLICY | 2021年 / 30卷
关键词
Cancer; Research activities; Government financing; Government grants and subsidies;
D O I
10.1016/j.jcpo.2021.100302
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Cancer research is a prominent theme on national and international development agendas. In many developed countries, funding for this area comes mainly from government sources. This article analyzes government funding of cancer research in Brazil, identifying the main funding instruments and examining the regional distribution of resources, research project and researcher profiles. Methods: Exploratory study of government funding of cancer research in Brazil between 2007 and 2016. The primary data were federal and state funding agencies. Results: A total of 8565 research awards were identified for the period 2007-2016. Amounting to almost US$489 million, these awards were linked to 7622 research projects and 3068 researchers. The proportion of grants awarded to women was slightly higher. It is noteworthy that just 3% of researchers received 20 % of the grants. The multiple-grant history of individual researchers seemed to be a conditioning factor for obtaining new grants/ fellowships. Funding was highly concentrated in the Southeast region, accounting for 84.4 % of total awards. There was a positive correlation between number of awards and amount awarded. The most frequently studied cancers were breast (11.8 %), head and neck (9.0 %) and skin cancer (5.3 %). Studies that did not specify the type of cancer accounted for 36.8 % of grants and 45.1 % of funding. Conclusion: The findings show a fall in the share of cancer research funding in the three largest funders. Cuts in government spending triggered by the country's political and economic crisis, highlight the vulnerability of science and technology. Greater transparency through access to information on funding, researcher, and research profiles is key to obtaining a better understanding the cancer research funding landscape in Brazil and reducing regional inequalities. Policy summary: A more centralized management of public cancer research funding and constant investment and monitoring is needed to ensure the effective implementation of funding policy.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Cancer research funding in Asia
    Cheng, Margaret Harris
    MOLECULAR ONCOLOGY, 2007, 1 (02): : 135 - 137
  • [42] Cancer research funding in USA
    Brown, Hannah
    MOLECULAR ONCOLOGY, 2007, 1 (02) : 128 - 130
  • [43] Cancer research funding in Europe
    Fricker, Janet
    MOLECULAR ONCOLOGY, 2007, 1 (02) : 131 - 134
  • [45] Government and charity funding of cancer research: public preferences and choices (vol 13, 38, 2015)
    Shah, Koonal Kirit
    Sussex, Jon
    Hernandez-Villafuerte, Karla
    HEALTH RESEARCH POLICY AND SYSTEMS, 2015, 13
  • [46] Funding for cancer research by an Indian funding agency, DBT
    Shenoy, Sandhya R.
    Dey, Bindu
    JOURNAL OF BIOSCIENCES, 2021, 46 (01)
  • [47] Funding for cancer research by an Indian funding agency, DBT
    Sandhya R Shenoy
    Bindu Dey
    Journal of Biosciences, 2021, 46
  • [48] Funding research in universities: do government resources act as a complement or substitute to industry funding?
    Wang, Yuandi
    Chen, Yu
    Li, Weiping
    Wang, Tao
    Guo, Lijia
    Li-Ying, Jason
    Huang, Jiashun
    ECONOMIC RESEARCH-EKONOMSKA ISTRAZIVANJA, 2020, 33 (01): : 1377 - 1393
  • [49] Severe funding cuts threaten the future of research in Brazil
    Redmond, Kendra
    MRS BULLETIN, 2017, 42 (04) : 268 - 269
  • [50] The landscape of biomedical research funding in Brazil: a current overview
    Gomes, Cristiano M.
    Marchini, Giovanni
    Junior, Jose de Bessa
    Carvalhal, Gustavo
    Caldeira, Marina P. R.
    Saldiva, Paulo Hilario
    Krieger, Jose Eduardo
    Agena, Fabiana
    Reis, Sabrina
    Paschoal, Candice
    Froes, Milena
    Srougi, Miguel
    Nahas, William C.
    Favorito, Luciano A.
    INTERNATIONAL BRAZ J UROL, 2024, 50 (02): : 209 - 222